Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pulsed field ablation
MedTech
Galvanize nets $100M, and a new CEO, to bring PFA to lung cancer
The company has named its chairman, Doug Godshall, as CEO amid a $100 million series C venture capital fundraising.
Conor Hale
Sep 4, 2025 1:00pm
FDA approves Kardium’s Globe pulsed field ablation catheter
Sep 3, 2025 11:00am
Boston Scientific bumps financial forecasts amid device gains
Jul 23, 2025 10:32am
J&J boosts outlook amid growing cardiac device sales
Jul 16, 2025 11:47am
Boston Scientific expands Farapulse afib reach with new approval
Jul 7, 2025 11:58am
PFA developer Field Medical raises $35M in quick-turn VC round
Jul 3, 2025 10:30am
